The Ministry of Trade, Agribusiness and Industry has announced a bold new initiative to revolutionize Ghana’s pharmaceutical sector through the launch of the PharmaVax Programme.
The programme, which was outlined at a meeting in Accra on Thursday, 25th June 2026, aims to strengthen governance, attract investment, and expand market opportunities for local manufacturers.
According to the ministry, the PharmaVax Programme is anchored on four key pillars: strengthening governance institutions within the pharmaceutical sector; enhancing public-private dialogue between government and industry; improving the environment for foreign direct investment and trade; and promoting greater transparency in investment conditions and authorization processes.
Speaking on behalf of the Hon. Minister Elizabeth Ofosu-Adjare, the Director of Administration, Mr. Yaw Sakyi, emphasized the government’s commitment to making Ghana the pharmaceutical manufacturing hub of the sub-region. He noted that the new Pharmaceutical Policy would provide the necessary implementation systems to ensure the sector’s growth. Mr. Sakyi also expressed gratitude to the European Union and the German Ministry for Economic Cooperation and Development for their financial support of €415,437.78.
As part of the initiative, Mr. Godfred Gobah, Head of the Pharmaceutical Manufacturing Development Unit, stated that the Ministry would actively engage the private sector and participate in both local and international events. These efforts are designed to boost the visibility of Ghana’s pharmaceutical industry and create new market access opportunities.
The Ministry expects the PharmaVax Programme to lay a solid foundation for achieving several strategic objectives by 2030. These include doubling the export value of pharmaceutical products within the ECOWAS market and increasing the market share of locally produced pharmaceuticals from 30 percent to 60 percent.
Working in partnership with GIZ Ghana, the European Union, and other key stakeholders, the Trade Ministry is focused on building a robust ecosystem to drive the growth and global competitiveness of Ghana’s pharmaceutical sector.
Source: Apexnewsgh.com